EX-FILING FEES 5 tm243480d2_ex-filingfees.htm EX-FILING FEES

 

Exhibit 107

 

Calculation of Filing Fee Tables

 

Form S-3

(Form Type)

 

Standard BioTools Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered Securities

 

               
Security
Type
  Security
Class
Title
  Fee
Calculation
Rule
  Amount
Registered
(1)
  Proposed
Maximum
Offering
Price Per
Unit
  Maximum
Aggregate
Offering
Price
  Fee
Rate
  Amount of
Registration
Fee
               
Equity      Common Stock, $0.001 par value per share   457(c)    38,428,964 (2)   $2.275(3)   $87,425,893.10   $0.00014760    $12,904.07
Total Offering Amounts       $87,425,893.10       $12,904.07
Total Fees Previously Paid              
Total Fee Offsets              
Net Fee Due               $12,904.07

 

(1)Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), Standard BioTools Inc. (the “Registrant”) is also registering an indeterminate number of additional shares of common stock, par value $0.001 per share (“Standard BioTools Common Stock”), that may become issuable as a result of any stock dividend, stock split, recapitalization or other similar transaction.

 

(2)Consists of (i) 26,736,975 shares of Standard BioTools Common Stock registered for sale by the selling securityholders named in this registration statement (including 5,009,801 of the shares of Standard BioTools Common Stock referred to in the following clause (ii)), (ii) 5,564,799 shares of Standard BioTools Common Stock issuable upon the exercise of Private Placement Warrants (as defined in the registration statement), and (iii) 6,127,190 shares of Standard BioTools Common Stock issuable upon the exercise of Public Warrants (as defined in the registration statement).

 

(3)Pursuant to Rule 457(c) under the Securities Act, and solely for the purpose of calculating the registration fee, the proposed maximum offering price per share is $2.275, which is the average of the high and low prices of the Standard BioTools Common Stock on January 16, 2024 on The Nasdaq Global Select Market.